Australia, March 31 -- ADARX PHARMACEUTICALS Inc., owns the trademark (2613396) for 'ADARX PHARMACEUTICALS' till Aug. 28, 2035.
Status: protected:
Registered/protected
Classes: 1 [Chemical compounds in the nature of nucleotides for scientific and research use; chemical compounds in the nature of nucleotides for use in the manufacture of pharmaceuticals.], 5 [Pharmaceutical preparations, namely, RNA-based therapeutics for use in the treatment of complement-mediated, immune-related, genetic, cardiovascular, central nervous system, and metabolic diseases, conditions, and disorders, and cancer.] and 42 [Development of pharmaceutical preparations and medicines; pharmaceutical products development; pharmaceutical research and development; scientific research and development in the field of RNA-based therapeutics; design and testing of RNA agents; bioinformatics and genomic data analysis for therapeutic development.]
Type of Mark: Word
Date of Acceptance: Jan. 23
Registration Advertised: March 30
For further details contact Greenfield & Sacks P.C. Christina M. Licursi Wolf.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2613396.
Disclaimer: Curated by HT Syndication.
